OJ-Bio was established in the UK in December 2008 as a joint venture between JRC and ORLA. The aim of OJ-Bio was to develop a unique technology by combining JRC's SAW technology with ORLA's protein technology to provide a POCT immunoassay product that could be used at home. OJ-Bio has received several UK grant projects on influenza, HIV, periodontal disease, etc., and has conducted basic research on SAW biosensors with JRC.
|
|
Since the basic technology developments at OJ-Bio had been completed and the aim of OJ-Bio had been fulfilled, OJ-Bio was dissolved in 2017. All assets of OJ-Bio were transferred to JRC, and JRC continued to try commercialization in Japan.
|
|
In 2019, JRC/UJRC obtained a PMDA product certificate of a CRP test kit in Japan, the first in vitro diagnostic product using SAW biosensors. Since the reader is palm-sized and can be carried in a bag for visiting doctors, JRC/UJRC have received some inquiries from visiting doctors, nursing care centers, and clinics in rural areas. However, as it was a new market, the market scale was small and insufficient to start commercialization.
|
|
In 2020, JRC decided to shrink the development project in Japan and continue to support for tstbio commercialization in Taiwan. JRC transferred the SAW biosensor technologies to tstbio. The palm-sized reader was taken over by tstbio, and all the protein-coating equipment was transferred to tstbio's plant in Taiwan. In addition, all of assets of OJ-Bio including Logo/Home page has also been transferred to tstbio from JRC.
|
|
tstbio is working on commercialization of SAW biosensor products and JRC is still supporting tstbio. |
==================
OJ-Bio: OJ-Bio Limited
ORLA: Orla Protein Technologies Ltd.
JRC: Japan Radio Co.,Ltd.
UJRC: Ueda Japan Radio Co.,Ltd.
TST: Tai-Saw technology Co., Ltd.
tstbio: tst biomedical electronics Co., Ltd